J
Javier A. Cepeda
Researcher at University of California, San Diego
Publications - 51
Citations - 1512
Javier A. Cepeda is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Harm reduction & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 16, co-authored 51 publications receiving 1172 citations. Previous affiliations of Javier A. Cepeda include Johns Hopkins University & University of California, Berkeley.
Papers
More filters
Journal ArticleDOI
Public health and international drug policy
Joanne Csete,Adeeba Kamarulzaman,Michel D. Kazatchkine,Frederick L. Altice,Marek Balicki,Julia Buxton,Javier A. Cepeda,Megan Comfort,Eric Goosby,João Goulão,Carl L. Hart,Thomas Kerr,Alejandro Madrazo Lajous,Stephen R. Lewis,Natasha K. Martin,Daniel Mejía,Adriana Camacho,David Scott Mathieson,Isidore Obot,Adeolu Ogunrombi,Susan G. Sherman,Jack Stone,Nandini Vallath,Peter Vickerman,Tomáš Zábranský,Chris Beyrer +25 more
TL;DR: The Johns Hopkins-Lancet Commission on Drug Policy and Health as mentioned in this paper examined the emerging scientific evidence on public health issues arising from drug control policy and to inform and encourage a central focus on health evidence and outcomes in drug-policy debates, such as the important deliberations of the 2016 UNGASS on drugs.
Journal ArticleDOI
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission
Linda-Gail Bekker,Linda-Gail Bekker,George Alleyne,Stefan Baral,Javier A. Cepeda,Demetre Daskalakis,David W. Dowdy,Mark Dybul,Serge Eholié,Kene Esom,Geoff Garnett,Anna Grimsrud,James Hakim,Diane V. Havlir,Michael T Isbell,Leigh F. Johnson,Adeeba Kamarulzaman,Parastu Kasaie,Michel Kazatchkine,Nduku Kilonzo,Michael J. Klag,Marina B. Klein,Sharon R Lewin,Chewe Luo,Keletso Makofane,Natasha K. Martin,Kenneth H. Mayer,Gregorio A. Millett,Ntobeko A.B. Ntusi,Loyce Pace,Carey Pike,Peter Piot,Anton Pozniak,Thomas C. Quinn,Thomas C. Quinn,Jürgen K. Rockstroh,Jirair Ratevosian,Owen Ryan,Serra Sippel,Bruno Spire,Agnes Soucat,Ann M Starrs,Steffanie A. Strathdee,Nicholas Thomson,Stefano Vella,Mauro Schechter,Peter Vickerman,Brian W. Weir,Chris Beyrer +48 more
TL;DR: Author(s): Bekker, Linda-Gail; Alleyne, George; Baral, Stefan; Cepeda, Javier; Daskalakis, Demetre; Dowdy, David; Kilonzo, Nduku; Klag, Michael; Klein, Marina; Lewin, Sharon R; Stars, Ann; Strathdee, Steffanie A; Thomson, Nicholas; Schechter, Mauro; Vickerman, Peter; Weir, Brian
Journal ArticleDOI
Responding to global stimulant use: challenges and opportunities.
Michael Farrell,Natasha K. Martin,Natasha K. Martin,Emily Stockings,Annick Borquez,Annick Borquez,Javier A. Cepeda,Louisa Degenhardt,Robert Ali,Lucy Thi Tran,Jürgen Rehm,Marta Torrens,Steve Shoptaw,Rebecca McKetin +13 more
TL;DR: No effective pharmacotherapies are available that reduce stimulant use, and the available psychosocial interventions had a weak overall effect, but generic approaches can address mental health and blood borne virus infection risk if better tailored to mitigate the harms associated with stimulants.
Journal ArticleDOI
Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
Jaimie P. Meyer,Javier A. Cepeda,Johnny Wu,Robert L. Trestman,Frederick L. Altice,Sandra A. Springer +5 more
TL;DR: Though just one-third of HIV-infected prisoners receiving ART entered correctional facilities with viral suppression, HIV treatment was optimized during incarceration, resulting in the majority achieving viral suppression by release.
Journal ArticleDOI
HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study
Jaimie P. Meyer,Javier A. Cepeda,Sandra A. Springer,Johnny Wu,Robert L. Trestman,Frederick L. Altice,Frederick L. Altice +6 more
TL;DR: Identification of individuals most at risk for recidivism and loss of viral suppression might mitigate the risk that repeated reincarceration poses to systems of public health and safety.